Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjli Kukreja

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Diabetes Technology & Therapeutics|August 8, 2002
NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence ratesAnjli Kukreja, Noel K Maclaren
Blood|August 8, 2009
Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone diseaseAnjli Kukreja, Soroosh Radfar, Ben-Hua Sun, et al.
Journal of Autoimmunity|November 7, 2002
NKT cell defects in NOD mice suggest therapeutic opportunitiesAnjli Kukreja, Guilia Costi, John Marker, et al.
Clinical and Translational Science|September 15, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy VolunteersAnjli Kukreja, Sascha Keller, Yury Shatillo, et al.
The Journal of Experimental Medicine|August 2, 2006
Enhancement of clonogenicity of human multiple myeloma by dendritic cellsAnjli Kukreja, Aisha Hutchinson, Kavita Dhodapkar, et al.
British Journal of Haematology|January 16, 2007
Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implicationsAnjli Kukreja, Aisha Hutchinson, Amitabha Mazumder, et al.
Blood|August 2, 2008
Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myelomaKavita M Dhodapkar, Scott Barbuto, Phillip Matthews, et al.
Blood|April 3, 2015
Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUSRoxanne Cofiell, Anjli Kukreja, Krystin Bedard, et al.
Infection and Immunity|May 13, 2009
Role of teichoic acid choline moieties in the virulence of Streptococcus pneumoniaeFlorian Gehre, Radek Spisek, Arun S Kharat, et al.
The Journal of Experimental Medicine|May 16, 2007
Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response programKavita M Dhodapkar, Devi Banerjee, John Connolly, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Diabetes Technology & Therapeutics|August 8, 2002
NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence ratesAnjli Kukreja, Noel K Maclaren
Blood|August 8, 2009
Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone diseaseAnjli Kukreja, Soroosh Radfar, Ben-Hua Sun, et al.
Journal of Autoimmunity|November 7, 2002
NKT cell defects in NOD mice suggest therapeutic opportunitiesAnjli Kukreja, Guilia Costi, John Marker, et al.
Clinical and Translational Science|September 15, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy VolunteersAnjli Kukreja, Sascha Keller, Yury Shatillo, et al.
The Journal of Experimental Medicine|August 2, 2006
Enhancement of clonogenicity of human multiple myeloma by dendritic cellsAnjli Kukreja, Aisha Hutchinson, Kavita Dhodapkar, et al.
British Journal of Haematology|January 16, 2007
Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implicationsAnjli Kukreja, Aisha Hutchinson, Amitabha Mazumder, et al.
Blood|August 2, 2008
Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myelomaKavita M Dhodapkar, Scott Barbuto, Phillip Matthews, et al.
Blood|April 3, 2015
Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUSRoxanne Cofiell, Anjli Kukreja, Krystin Bedard, et al.
Infection and Immunity|May 13, 2009
Role of teichoic acid choline moieties in the virulence of Streptococcus pneumoniaeFlorian Gehre, Radek Spisek, Arun S Kharat, et al.
The Journal of Experimental Medicine|May 16, 2007
Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response programKavita M Dhodapkar, Devi Banerjee, John Connolly, et al.
Pageof 2